Global Blood Risk Adjusted Performance

GBTDelisted Stock  USD 68.49  0.00  0.00%   
Global Blood risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Global Blood Therapeutics or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Global Blood Therapeutics has current Risk Adjusted Performance of 0.1164.

RAP

 = 

(ER[a] - RFR) * STD[b])/STD[b]

RFR

 = 
0.1164
ER[a] = Expected return on investing in Global Blood
RFR = Risk Free Rate of return. Typically T-Bill Rate
STD[b] =   Standard Deviation of selected market or benchmark.

Global Blood Risk Adjusted Performance Peers Comparison

Global Risk Adjusted Performance Relative To Other Indicators

Global Blood Therapeutics is one of the top stocks in risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies reporting about  360.41  of Maximum Drawdown per Risk Adjusted Performance. The ratio of Maximum Drawdown to Risk Adjusted Performance for Global Blood Therapeutics is roughly  360.41 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas